BioWorld

Aug. 23, 2002

View Archived Issues

FDA Plans Oversight Changes At Drug Manufacturing Facilities

WASHINGTON - The FDA intends to catch up with advancing technology and science by implementing a plan to upgrade its system of monitoring the manufacturing facilities that make biologics, drugs and veterinarian products. (BioWorld Today) Read More

NeoTherapeutics Restructures To Focus On Cancer, Out-Licensing

Read More

A Molecule Named DARPP-32 Is Powerful Performer In Caffeine's Little-Known Psychostimulation

Read More

Zapaq Plans $14M Financing To Exploit Alzheimer's Discoveries

Read More

Other News To Note

Read More